Published: February 03, 2011
TVG's BioPartnering North America Conference Supports Future Industry Leaders Through a Unique Mentoring Program, Participation of Students in Partnering and Networking Sessions, and the Award of Life Science Student Bursaries
SANTA CRUZ, Calif. - (BUSINESS WIRE) - Technology Vision Group (TVG) is pleased to announce that the upcoming BioPartnering
North America (BPN) conference, being held on 27 February - 1 March
2011 at the Vancouver Convention Centre in Canada, will include three
unique programs that help build the future of the industry through
business development leadership, mentoring and life science student
bursaries.
Industry professionals attending BPN will have the opportunity to
participate in the BioMentorz
course - a unique and intensive training session designed to mentor
business development professionals as they move up the career ladder.
BioMentorz is led by a faculty of accomplished and deeply skilled
business development dealmakers who collectively have close to one
hundred years in business development experience. Jack Anthony, Gayle
Mills and Dick Haiduck of BioMentorz are recognized in the business
development field as having an incredible breadth and depth of
experience and insight. The BioMentorz team is dedicated to helping the
next generation of industry leaders hone their skills and advance in
their business development roles.
"Jack is an accomplished deal guy and really understands 'the secret
sauce.' Dick is a strategist - having been a CEO or Managing Director of
six different organizations in the USA and abroad. Gayle is a well-known
business development executive with deep roots in sales and marketing
and she uses those strengths to create appropriate commercialization
strategies. TVG is delighted to bring this opportunity to learn from
such experienced industry leaders to our clients at BioPartnering North
America." Dr. Robert Lee Kilpatrick, Partner, TVG
BioPartnering North America also provides a unique opportunity for
members of the Student Biotechnology Network (SBN) who attend SBN's
Biotech Expo & Conference to participate in BioPartnering North America
from 14:00 - 18:00 on Tuesday, 1 March. Students will learn firsthand
about the industry from local and global industry leaders, see how
partnering deals are made in face-to-face partnering meetings and
participate in one of the largest global life science partnering
conferences. Students are also invited to connect with industry leaders
at a special networking reception.
Finally, the TVG
/ BIOTECanada Student Bursary program, now in its ninth year, is
designed to support graduate and post-graduate students in a
biotechnology-related program in Canada to attend the BioPartnering
North America (BPN) conference. This bursary provides a great
opportunity for students to learn about the global biotech industry by
attending information sessions and participating in networking events
with peers and potential employers.
"BioPartnering North America was a wonderful experience. I was
exposed to the global biotechnology and pharmaceutical community, and
had a chance to learn about leading edge technologies. In addition to
enhancing my educational experience, this opportunity was an invaluable
networking event that enabled me to strengthen my professional skills." Gigi
Ho, TVG / BIOTECanada Student Bursary recipient.
The bursary provides full registration to the conference, travel costs
(for students residing outside the Greater Vancouver Area), and
accommodation for 2 nights close to the conference venue.
About BioMentorz
BioMentorz is a South San Francisco-based firm representing a unique
approach to increasing the productivity of companies without outsourcing
functional management or producing large and generally unread reports.
We roll up our sleeves. Even the most talented, bright, veteran senior
manager in today's complex environment can benefit from tapping into
perspectives and experiences outside their immediate sphere. BioMentorz
is a group of experienced managers who have built companies, sold
companies, closed companies, done deals, raised capital and dealt with
Boards and investors. We stand behind our clients assisting them address
strategic imperatives as well as tactical needs. We can be project
oriented, mentor oriented and/or strategy oriented, whatever makes sense
for building value with you, for you and from behind the curtains.
www.biomentorz.com
About SBN
The SBN is a student driven and led, not-for-profit organization that
provides students an autonomous forum to discuss and explore interests
in biotechnology and the life sciences. Through interactive lectures,
career fairs, networking events, and unique mentorship opportunities,
SBN builds bridges between students and the local biotech sector to help
prepare industry-ready graduates. Since its inception in 2001, the SBN
has grown to be the largest network of its kind in Western Canada.
www.thesbn.ca
About BIOTECanada
BIOTECanada is the national non-profit association dedicated to building
the bio-based economy in Canada. From cleaner energy to sustainable
agriculture, from greener manufacturing to life-saving health therapies,
Canadian biotech firms are discovering ways to revolutionize the economy
and improve our lives, everyday.
www.biotech.ca
About Technology Vision Group (TVG)
Technology Vision Group LLC (TVG) is the leading networking development
organization serving the international life sciences industry. Since
1992, TVG has been developing innovative methods to help life science
and associated technology companies attract partners and investors,
acquire new products and technologies, and achieve a variety of other
strategic business development goals.
For more information visit www.techvision.com
Producers
TVG and LifeSciences British Columbia
Hosts
BioAlberta and BIOTECanada
2011 Prodium Presenters and Exhibitors (As of 2 February 2011)
3M Drug Delivery Systems; Æterna
Zentaris Inc.; AbGenomics
International Inc.; Affibody
AB; AIM
Therapeutics; Amakem
NV; Amorfix;
AMT Amsterdam Molecular Therapeutics; Anaphore, Inc.; Antibe
Therapeutics Inc.; Arena Pharmaceuticals, Inc.; Armour Therapeutics Inc.;
Augurex Life Sciences Corp.; BellBrook
Labs; biOasis
Technologies Inc.; Biomedical
Consulting International, Inc.; Can-Fite
BioPharma Ltd; Canadian Institutes of Health Research; CIRION
Clinical Trial Services Inc.; Critical Outcome Technologies Inc.
(COTI); Crown Bioscience Inc.; Cytochroma Inc.; Debiopharm S.A.;
DelMar Pharmaceuticals; Delphi Genetics; DSM Biologics; DSM
Pharma Chemicals; Elan Corporation; Eliapharma Services
Inc.; enGene, Inc.; Ensemble Therapeutics Corp.; Eurand
International S.p.A.; Ezose Sciences Inc.; Fluorinov Pharma Inc.;
Forma Therapeutics, Inc.; GenomeDx Biosciences Inc.; GVK
Biosciences Private Limited; Hennig Arzneimittel GmbH; Inovio
Pharmaceuticals, Inc.; Life Chemicals Inc.; Lupin Limited;
MedGenesis Therapeutix Inc.; Miami Mice Research Corp.; Micromyx, LLC;
MingSight Pharmaceuticals; Molecular Connections, India; Nektar
Therapeutics; NeuroQuest; NexMed (U.S.A.) Inc., a wholly-owned
subsidiary of Apricus Biosciences, Inc.; NKT Therapeutics; OncoGenex
Pharmaceuticals Inc.; onkovis GmbH; Otonomy, Inc.; Oxford BioMedica plc;
Pfenex Inc.; Pharnext; Phoenix PharmaLabs, Inc.; Pipeline Biopharm;
Piramal Healthcare; Plant Advanced Technologies; PlantForm; PolyMedix,
Inc.; Prestwick Chemical, Inc.; Probiodrug AG; Resverlogix Corp.; Rigel
Pharmaceuticals, Inc.; Roowin SA; RXi Pharmaceuticals Inc.; Semler
Research; Sernova Corp.; Sinoveda Canada, Inc.; Sirius Genomics; Somnus
Therapeutics Inc.; SuperGen Inc.; SuppreMol GmbH; Teva Innovative
Ventures; The University of Hong Kong Clinical Trials Centre; Therapure
Biopharma Inc.; Unigene Laboratories, Inc.; Valocor Therapeutics, Inc.;
Verisante Technology, Inc.; viDA Therapeutics Inc.; Viron Therapeutics;
Wimasis GmbH; WuXi AppTech Co., Ltd; YM Biosciences; Zalicus Inc.; ZS
Pharma, Inc.
Sponsors
Premium
AstraZeneca
Platinum
British Columbia Ministry of Tourism, Trade and Investment; UBIFrance /
French Trade Commission
Gold
Bristol-Myers Squibb Company; British Columbia Innovation Council;
Centre For Drug Research and Development (CDRD); Genome British
Columbia; Italian Trade Commission; Merck & Co., Inc.; Deloitte Recap
LLC; Novartis; OncoMed Pharmaceuticals
Silver
BC Cancer Agency; Farris, Vaughan, Willis & Murphy LLP; Fish &
Richardson; Pfizer; Student Biotechnology Network (SBN)
Conference Sponsors
Cooley LLP; Nature Publishing Group (NPG); Ogilvy Renault
Conference Supporter
AusBiotech; General Biologic
Media Sponsors
Business Wire; Contact Canada; Current Agreements; Current Partnering;
European BioPharmaceutical Review (EBR)
Media Supporters
BioBusiness; BioCentury; Biotechnology Focus; Bio-IT World; Cell Therapy
News; Fierce Biotech; Innovaro Pharmalicensing; Pharmatching;
PharmaVentures; PharmaVoice; The Scientist; Thomson Reuters
Regional Affiliates
Spanish Association of Biotech Companies (ASEBIO); BioForward; BioNJ;
BioNova; Colorado BioScience Association; Georgia Bio; Indiana Health
Industry Forum; Life Science Association of Manitoba; San Jose
BioCenter; Queensland Clinical Trials Network (QCTN)
Technology Vision Group LLC
Rebecca Angelos, Managing Director
Tel:
+1.831.464.4230 x153
Email: rangelos@techvision.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
